Neogen Chemicals Limited

Neogen Chemicals Limited

Neogen Chemicals Limited has announced its Q1 FY27 earnings conference call transcript, highlighting a strong performance with 34% year-on-year revenue growth, 53% year-on-year EBITDA growth, and 67% year-on-year profit after tax growth. The company has also initiated cost pass-through mechanisms with customers and has received cumulative insurance recoveries of INR 164 crore.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about a copy of a newspaper publication regarding the notice of its 37th Annual General Meeting (AGM) to be held on August 21, 2026, through video conferencing and Other Audio-Visual Means (OAVM).

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange that the Record Date for the purpose of Dividend is 13-Aug-2026. The Register of Members and Share Transfer Register will remain closed from Friday, August 14, 2026 to Friday, August 21, 2026 for ascertaining eligible members for the dividend, if approved at the 37th Annual General Meeting.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 21, 2026. The company has submitted the Integrated Annual Report for the financial year 2025-26 and has provided facility to its Members to exercise their right to vote by electronic means.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about the Earnings Conference Call Recording, hosted on the company's website.

Neogen Chemicals Limited

Neogen Chemicals Limited has hosted an analysts/investors conference call and made the recording available on their website.

Neogen Chemicals Limited

Neogen Chemicals Limited has announced its unaudited financial results for Q1 FY27, showing a 37% growth in revenue and 39% growth in EBITDA, with strong performance in Organolithium and Battery Chemicals. The company has also provided an update on the Dahej fire incident, with cumulative recoveries of INR 164 crore to date.

Neogen Chemicals Limited

Neogen Chemicals Limited has released its Q1 FY27 earnings presentation, showing strong revenue growth of 37% YoY, driven by higher volumes and product mix, with EBITDA margins expanding by 30bps. The company has also made progress in recovering from the Dahej fire incident, with cumulative recoveries of INR 164 crore.

Neogen Chemicals Limited

Neogen Chemicals Limited reported robust financial performance for Q1 FY27 with revenue at INR 250 crore, higher by 34% Y-o-Y, and PAT at INR 17 crore, an increase of 67% Y-o-Y.

Neogen Chemicals Limited

Neogen Chemicals Limited has submitted a statement of deviation or variation in the utilization of funds raised through a preferential issue for the quarter ended June 30, 2026, and has also enclosed a monitoring agency report from CRISIL Ratings Limited. The company has confirmed that there has been no deviation or variation in the utilization of proceeds.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the utilization of funds raised through Preferential Issue for the quarter ended June 30, 2026. The company has confirmed that there has been no deviation or variation in the utilization of proceeds of funds raised through issue of Equity Shares on preferential basis.

Neogen Chemicals Limited

Neogen Chemicals Limited has issued a Monitoring Agency Report and Statement of Deviation/Variation in utilisation of funds raised through Preferential Issue for the quarter ended June 30, 2026. The report has been reviewed by the Audit Committee and there has been no deviation or variation in the utilization of proceeds. The funds were raised for investment in wholly owned subsidiaries, meeting working capital requirements, and general corporate purposes. The amount utilized for general corporate purposes does not exceed 25% of the gross proceeds.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32 regarding the utilization of funds raised through Preferential Issue for the quarter ended June 30, 2026. The company has confirmed that there has been no deviation or variation in the utilization of proceeds of funds raised through issue of Equity Shares on preferential basis.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about Qualified Institutional Placement and other permissible modes for raising of funds. The company has also approved its un-audited financial results for the quarter ended June 30, 2026, and granted in-principle approval for raising of funds up to Rs. 600 crores.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange regarding Change in Auditors of the company. The Board of Directors had at its meeting held today considered and approved various items including the Un-audited (Standalone & Consolidated) Financial Results of the Company for the quarter ended June 30, 2026, and the convening of the 37th Annual General Meeting (AGM) of the Company on Friday, August 21, 2026.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026, approving financials for the quarter ended June 30, 2026, Integrated Report for FY 2025-26, and convening of AGM.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange that the Record date for the purpose of Dividend is 13-Aug-2026. The company has also approved its Un-audited Financial Results for the quarter ended June 30, 2026, and other matters.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange regarding Outcome of Board Meeting held on July 24, 2026, where the board approved a fund-raising plan.

Neogen Chemicals Limited

Neogen Chemicals Limited has announced its financial results for the quarter ended June 30, 2026, and has also approved the appointment of an internal auditor, CNK & Associates, for FY 2026-27. The company has also granted in-principle approval for raising funds up to Rs. 600 crores through various means, including QIP, and has increased its borrowing powers under section 180(1)(c) of the Companies Act, 2013, up to Rs. 500 crores.

Neogen Chemicals Limited

Neogen Chemicals Limited has informed the Exchange about the transfer of equity shares of the Company to the Investor Education and Protection Fund (IEPF) Authority.